Literature DB >> 21857879

Chronic inflammatory demyelinating polyneuropathy in a patient infected with human T lymphotropic virus type I.

Amza Ali1, Gurendra Char, Barrie Hanchard.   

Abstract

A 32-year-old Afro-Caribbean woman presented with a 1-year history of slowly progressive sensory and motor symptoms initially affecting the legs and later involving the arms. Clinical examination demonstrated a mainly distal pattern of weakness with little objective sensory impairment. The clinical features suggested the possibility of chronic inflammatory demyelinating polyneuropathy. This diagnosis was supported by neurophysiological testing and examination of the cerebrospinal fluid and confirmed by sural nerve biopsy as well as by exclusion of other causes of neuropathy. Seropositivity for human T lymphotropic virus type I (HTLV-I) was demonstrated. The clinical significance of this finding in an area with a high HTLV-I endemicity, as well as its possible aetiological relevance to the diagnosis of chronic inflammatory demyelinating polyneuropathy, is discussed.

Entities:  

Year:  2009        PMID: 21857879      PMCID: PMC3027780          DOI: 10.1136/bcr.03.2009.1680

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  HTLV-1 and HIV infections of the central nervous system in tropical areas.

Authors:  P Cabre; D Smadja; A Cabié; C R Newton
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-05       Impact factor: 10.154

2.  Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  Alan R Berger; Walter G Bradley; Thomas H Brannagan; Neil A Busis; Didier P Cros; Marinos C Dalakas; Moris J Danon; Peter Donofrio; W King Engel; John D England; Eva L Feldman; Roy L Freeman; Laurence J Kinsella; David Lacomis; Norman Latov; Daniel L Menkes; Howard W Sander; Florian P Thomas; William J Triggs; Anthony J Windebank; Gil I Wolfe
Journal:  J Peripher Nerv Syst       Date:  2003-12       Impact factor: 3.494

Review 3.  Diagnosis of CIDP.

Authors:  Norman Latov
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

4.  Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants.

Authors:  E L Murphy; J P Figueroa; W N Gibbs; M Holding-Cobham; B Cranston; K Malley; A J Bodner; S S Alexander; W A Blattner
Journal:  Am J Epidemiol       Date:  1991-06-01       Impact factor: 4.897

Review 5.  Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  J-M Vallat
Journal:  Postgrad Med J       Date:  2008-07       Impact factor: 2.401

Review 6.  Human T-cell lymphotropic virus type I-associated facial nerve palsy in Trinidad and Tobago.

Authors:  C Bartholomew; F Cleghorn; N Jack; J Edwards; W Blattner
Journal:  Ann Neurol       Date:  1997-06       Impact factor: 10.422

7.  Low-titer antibodies reactive with HTLV-I gag p19 in patients with chronic myeloneuropathy.

Authors:  T Kawanishi; I Akiguchi; M Fujita; M Kameyama; M Hatanaka
Journal:  Ann Neurol       Date:  1989-10       Impact factor: 10.422

8.  Clinicopathological and virological analyses of familial human T-lymphotropic virus type I--associated polyneuropathy.

Authors:  Hirofumi Sawa; Toshiko Nagashima; Kazuo Nagashima; Toshiya Shinohara; Takayo Chuma; Yukio Mano; Nobutada Tachi; William W Hall
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

9.  Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): A Review of Clinical Syndromes and Treatment Approaches in Clinical Practice.

Authors:  Kenneth C Gorson; Allan H Ropper
Journal:  J Clin Neuromuscul Dis       Date:  2003-06

10.  Peripheral neuropathy in HTLV-I infected individuals without tropical spastic paraparesis/HTLV-I-associated myelopathy.

Authors:  Ana C C Leite; Marcus Tulius T Silva; Alexandre H Alamy; Cristiane R A Afonso; Marco A D Lima; Maria J Andrada-Serpa; Osvaldo J M Nascimento; Abelardo Q-C Araújo
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.